Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 590 across all filing types
Latest filing 2018-12-10 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
RaySearch expands product line-up with a treatment control system, RayCommand, and recieves order from AVO
Regulatory Filings Classification · 95% confidence The document is explicitly titled '# **PRESS RELEASE STOCKHOLM, 10 DECEMBER 2018**' and announces a business development: RaySearch expanding its product line with a new treatment control system (RayCommand) and receiving an order from AVO. It details the product, the customer, and the financial impact (order value and revenue anticipation). The concluding paragraph states: '*This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.*' This structure—a press release announcing significant business news, often related to contracts or product launches, and referencing market regulation obligations—is characteristic of a general regulatory announcement or press release that doesn't fit the specific financial report categories (like 10-K, ER, or IR). Since it is a formal announcement of a business event mandated for public disclosure, and it doesn't fit the definitions for DIV, DIRS, MANG, or specific financial reports, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements.
2018-12-10 English
RaySearch utökar produktportföljen med behandlingskontrollsystemet RayCommand och får order från AVO
Regulatory Filings Classification · 98% confidence The document is a press release dated December 10, 2018, announcing that RaySearch is developing a new Treatment Control System (TCS) called RayCommand and has received an order for it from Advanced Oncotherapy plc (AVO). It details the product expansion, the order value (3.6 MEUR), and the expected revenue timeline. The text explicitly states: "*Denna information är sådan information som RaySearch Laboratories AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning.*" This indicates a mandatory regulatory disclosure regarding a significant business event (new product launch tied to a major contract). Since this is a general business announcement that doesn't fit the specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS), it falls best under the general regulatory announcement category, which is Regulatory Filings (RNS). It is not a full financial report (10-K or IR) nor a presentation (IP).
2018-12-10 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding for an instrument, noting the 'Before the transaction' and 'After the transaction' quantities, and stating the 'Reason for major shareholding notification Buy'. It reports the new percentage of voting rights (5.94%) and the total number of shares held (1,535,000). This content directly corresponds to the definition of a Major Shareholding Notification, which tracks when an investor crosses ownership thresholds. The corresponding code is MRQ.
2018-12-03 English
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding percentage for a specific holder ('OppenheimerFunds, Inc.') in the issuer ('RaySearch Laboratories AB (publ)'). It provides 'Before the transaction' and 'After the transaction' figures, including the new share quantity (3,516,727) and the resulting percentage (10.258% directly held shares, 3.18609% indirectly held voting rights). This structure perfectly matches the definition of a Major Shareholding Notification, which reports when ownership crosses certain thresholds. The code for this is MRQ.
2018-11-21 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'DELÅRSRAPPORT 1 JANUARI – 30 SEPTEMBER' (Interim Report) and provides comprehensive financial data, including income statements, cash flow, and management commentary for the third quarter and the first nine months of 2018. It contains detailed financial tables and analysis of business performance, fitting the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-15 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY 1-SEPTEMBER 30, 2018' and contains detailed financial statements, including income statements, cash flow data, and management commentary on performance for the third quarter and the first nine months of 2018. It provides substantive financial analysis and data, meeting the criteria for an Interim/Quarterly Report (IR). 9M 2018
2018-11-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.